Abstract
Rationale
The disaccharide trehalose protects cells from hypoxic and anoxic injury and suppresses protein aggregation. In vivo studies with trehalose show cellular and behavioral beneficial effects in animal models of neurodegenerative diseases. Moreover, trehalose was shown to enhance autophagy, a process that had been recently suggested to be involved in the therapeutic action of antidepressant and mood-stabilizing drugs.
Objective
The present study was therefore designed to explore antidepressant and mood-stabilizing activity of trehalose in animal models for depression and mania.
Methods
Trehalose 1 or 2 % was administered for 3 weeks as a drinking solution to Black Swiss mice (a model of manic-like behaviors) or 2 % to ICR mice and their behavior evaluated in a number of tests related to depression or mania. The effects of trehalose were compared with similar chronic administration of the disaccharide maltose as well as with a vehicle (water) control.
Results
Chronic administration of trehalose resulted in a reduction of frontal cortex p62/beclin-1 ratio suggesting enhancement of autophagy. Trehalose had no mood-stabilizing effects on manic-like behavior in Black Swiss mice but instead augmented amphetamine-induced hyperactivity, an effect similar to antidepressant drugs. In ICR mice, trehalose did not alter spontaneous activity or amphetamine-induced hyperactivity but in two separate experiments had a significant effect to reduce immobility in the forced swim test, a standard screening test for antidepressant-like effects.
Conclusions
The results suggest that trehalose may have antidepressant-like properties. It is hypothesized that these behavioral changes could be related to trehalose effects to enhance autophagy.
This is a preview of subscription content,
to check access.




References
Aguib Y, Heiseke A, Gilch S, Riemer C, Baier M et al (2009) Autophagy induction by trehalose counteracts cellular prion infection. Autophagy 5(3):361–369
Arora A, Ha C, Park CB (2004) Inhibition of insulin amyloid formation by small stress molecules. FEBS Lett 564(1–2):121–125
Autry AE, Adachi M, Nosyreva E, Na ES, Los MF et al (2011) NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475(7354):91–95
Bachmann RF, Schloesser RJ, Gould TD, Manji HK (2005) Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics. Mol Neurobiol 32(2):173–202
Beasley CL, Pennington K, Behan A, Wait R, Dunn MJ et al (2006) Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: evidence for disease-associated changes. Proteomics 6(11):3414–3425
Behan AT, Byrne C, Dunn MJ, Cagney G, Cotter DR (2009) Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in lamp, stxbp1 and basp1 protein expression. Mol Psychiatry 14(6):601–613
Bennett GS, Hollander BA, Laskowska D, DiLullo C (1991) Rapid degradation of newly synthesized tubulin in lithium-treated sensory neurons. J Neurochem 57(1):130–139
Calabrese F, Molteni R, Racagni G, Riva MA (2009) Neuronal plasticity: a link between stress and mood disorders. Psychoneuroendocrinology 34(Suppl 1):S208–216, Epub
Cambiaghi M, Cursi M, Magri L, Castoldi V, Comi G et al (2012) Behavioural and eeg effects of chronic rapamycin treatment in a mouse model of tuberous sclerosis complex. Neuropharmacology 67C:1–7. doi:10.1016/j.neuropharm.2012.1011.1003
Cannell GR, Bailey MJ, Dickinson RG (2002) Inhibition of tubulin assembly and covalent binding to microtubular protein by valproic acid glucuronide in vitro. Life Sci 71(22):2633–2643
Chen Q, Haddad GG (2004) Role of trehalose phosphate synthase and trehalose during hypoxia: from flies to mammals. J Exp Biol 207(Pt 18):3125–3129
Cleary C, Linde JA, Hiscock KM, Hadas I, Belmaker RH et al (2008) Antidepressive-like effects of rapamycin in animal models: implications for mtor inhibition as a new target for treatment of affective disorders. Brain Res Bull 76(5):469–473
Cloonan SM, Williams DC (2011) The antidepressants maprotiline and fluoxetine induce type ii autophagic cell death in drug-resistant burkitt's lymphoma. Int J Cancer 128(7):1712–1723
Costain WJ, Haqqani AS, Rasquinha I, Giguere MS and Slinn J (2012) Cerebral ischemia induced proteomic alterations: consequences for the synapse and organelles. Advances in the Preclinical Study of Ischemic Stroke. M Balestrino
Cryan JF, O'Leary OF (2010) Neuroscience. A glutamate pathway to faster-acting antidepressants? Science 329(5994):913–914
de Felipe MC, Jimenez I, Castro A, Fuentes JA (1989) Antidepressant action of imipramine and iprindole in mice is enhanced by inhibitors of enkephalin-degrading peptidases. Eur J Pharmacol 159(2):175–180
Dengjel J, Hoyer-Hansen M, Nielsen MO, Eisenberg T, Harder LM et al (2012) Identification of autophagosome-associated proteins and regulators by quantitative proteomic analysis and genetic screens. Mol Cell Proteomics 11(3):M111–014035
Dwyer JM, Lepack AE, Duman RS (2011) Mtor activation is required for the antidepressant effects of mglur2/3 blockade. Int J Neuropsychopharmacol 24:1–6
Dziedzicka-Wasylewska M, Faron-Gorecka A, Rogoz Z, Solich J (2004) The effect of combined treatment with imipramine and amantadine on the behavioral reactivity of central alpha1-adrenergic system in rats. Behav Pharmacol 15(2):159–165
Einat H, Manji HK (2006) Cellular plasticity cascades: gene to behavior pathways in animal models of bipolar disorder. Biol Psychiatry 59(12):1960–1971
Flaisher-Grinberg S, Einat H (2009) A possible utilization of the mice forced swim test for modeling manic-like increase in vigor and goal-directed behavior. J Pharmacol Toxicol Methods 59(3):141–145
Flaisher-Grinberg S, Einat H (2010) Strain specific battery of tests for separate behavioral domains of mania. Front Psychiatry 1(Article 10):1–10
Flaisher-Grinberg S, Overgaard S, Einat H (2009) Attenuation of high sweet solution preference by mood stabilizers: a possible mouse model for the increased reward-seeking domain of mania. J Neurosci Methods 177(1):44–50
Garcia LS, Comim CM, Valvassori SS, Reus GZ, Barbosa LM et al (2008) Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases bdnf levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry 32(1):140–144, Epub 2007
Gould TD, Einat H, O'Donnell KC, Picchini AM, Schloesser RJ et al (2007a) Beta-catenin overexpression in the mouse brain phenocopies lithium-sensitive behaviors. Neuropsychopharmacology 32(10):2173–2183
Gould TD, O'Donnell KC, Picchini AM, Manji HK (2007b) Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical response to lithium. Neuropsychopharmacology 32(6):1321–1333
Gould TD, Picchini AM, Einat H, Manji HK (2006) Targeting glycogen synthase kinase-3 in the cns: implications for the development of new treatments for mood disorders. Curr Drug Targets 7(11):1399–1409
Hannah-Poquette C, Anderson GW, Flaisher-Grinberg S, Wang J, Meinerding TM et al (2011) Modeling mania: further validation for black swiss mice as model animals. Behav Brain Res 223(1):222–226
He C, Klionsky DJ (2009) Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 43:67–93
Higashiyama T (2002) Novel functions and applications of trehalose. Pure Appl Chem 74(7):1263–1269
Hiscock KM, Linde JA and Einat H (2007). Black swiss mice as a new animal model for mania: a preliminary study. J Med Biol Sci 1(2)
Kalinichev M, Dawson LA (2011) Evidence for antimanic efficacy of glycogen synthase kinase-3 (gsk-3) inhibitors in a strain specific model of acute mania. Int J Neuropsychopharmacol 6:1–17
Kampov-Polevoy AB, Garbutt JC, Janowsky DS (1999) Association between preference for sweets and excessive alcohol intake: a review of animal and human studies. Alcohol Alcohol 34(3):386–395
Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G et al (2008) Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4(2):151–175
Lang UE, Heger J, Willbring M, Domula M, Matschke K et al (2009) Immunosuppression using the mammalian target of rapamycin (mtor) inhibitor everolimus: pilot study shows significant cognitive and affective improvement. Transplant Proc 41(10):4285–4288
Leliveld SR, Bader V, Hendriks P, Prikulis I, Sajnani G et al (2008) Insolubility of disrupted-in-schizophrenia 1 disrupts oligomer-dependent interactions with nuclear distribution element 1 and is associated with sporadic mental disease. J Neurosci 28(15):3839–3845
Li N, Lee B, Liu RJ, Banasr M, Dwyer JM et al (2010) Mtor-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329(5994):959–964
Maj J (1984) Central effects following repeated treatment with antidepressant drugs. Pol J Pharmacol Pharm 36(2–3):87–99
Maj J, Wedzony K (1985) Repeated treatment with imipramine or amitriptyline increases the locomotor response of rats to (+)-amphetamine given into the nucleus accumbens. J Pharm Pharmacol 37(5):362–364
Piazza PV, Deminiere JM, le Moal M, Simon H (1990) Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Res 514(1):22–26
Porsolt RD, Anton G, Blavet N, Jalfre M (1978a) Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47(4):379–391
Porsolt RD, Bertin A, Jalfre M (1978b) “Behavioural despair” in rats and mice: strain differences and the effects of imipramine. Eur J Pharmacol 51(3):291–294
Racagni G, Popoli M (2008) Cellular and molecular mechanisms in the long-term action of antidepressants. Dialogues Clin Neurosci 10(4):385–400
Robinson TE, Becker JB (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 396(2):157–198
Rodriguez-Navarro JA, Rodriguez L, Casarejos MJ, Solano RM, Gomez A et al (2010) Trehalose ameliorates dopaminergic and tau pathology in parkin deleted/tau overexpressing mice through autophagy activation. Neurobiol 39(3):423–438
Sarkar S, Perlstein EO, Imarisio S, Pineau S, Cordenier A et al (2007) Small molecules enhance autophagy and reduce toxicity in huntington's disease models. Nat Chem Biol 3(6):331–338
Sarkar S, Rubinsztein DC (2006) Inositol and ip3 levels regulate autophagy: biology and therapeutic speculations. Autophagy 2(2):132–134
Shamir A, Elhadad N, Belmaker RH, Agam G (2005) Interaction of calbindin d28k and inositol monophosphatase in human postmortem cortex: possible implications for bipolar disorder. Bipolar Disord 7(1):42–48
Singer MA, Lindquist S (1998) Multiple effects of trehalose on protein folding in vitro and in vivo. Mol Cell 1(5):639–648
Tanaka M, Machida Y, Niu S, Ikeda T, Jana NR et al (2004) Trehalose alleviates polyglutamine-mediated pathology in a mouse model of huntington disease. Nat Med 10(2):148–154, Epub 2004
Taylor JP, Hardy J, Fischbeck KH (2002) Toxic proteins in neurodegenerative disease. Science 296(5575):1991–1995
Tottori K, Miwa T, Uwahodo Y, Yamada S, Nakai M et al (2001) Antidepressant-like responses to the combined sigma and 5-ht1a receptor agonist opc-14523. Neuropharmacology 41(8):976–988
Vezina P, Giovino AA, Wise RA, Stewart J (1989) Environment-specific cross-sensitization between the locomotor activating effects of morphine and amphetamine. Pharmacol Biochem Behav 32(2):581–584
Wang J, Flaisher-Grinberg S, Li S, Liu H, Sun L et al (2010) Antidepressant-like effects of the active acidic polysaccharide portion of ginseng in mice. J Ethnopharmacol 132(1):65–69
Willner P, Towell A, Sampson D, Sophokleous S, Muscat R (1987) Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl) 93(3):358–364
Yang CR, Yu RK (2009) Intracerebral transplantation of neural stem cells combined with trehalose ingestion alleviates pathology in a mouse model of huntington's disease. J Neurosci Res 87(1):26–33
Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R et al (2006) A randomized trial of an n-methyl-d-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63(8):856–864
Zschocke J, Zimmermann N, Berning B, Ganal V, Holsboer F, et al (2011) Antidepressant drugs diversely affect autophagy pathways in astrocytes and neurons-dissociation from cholesterol homeostasis. Neuropsychopharmacology 2011: 20
Acknowledgments
The study was partially supported by a grant from the United States–Israel Binational Science Foundation to Haim Einat and Grant W Anderson (grant # 2011313). The authors would like to thank the Endowment for Medical Research (Huston, TX) for their generous donation of trehalose. We would also like to thank Dr. Shlomit Flaisher-Grinberg, Ms. Sara Schuster, Ms. Keren Raphael, and Mr. Jesse Juetten for their technical assistance.
Conflict of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kara, N.Z., Toker, L., Agam, G. et al. Trehalose induced antidepressant-like effects and autophagy enhancement in mice. Psychopharmacology 229, 367–375 (2013). https://doi.org/10.1007/s00213-013-3119-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-013-3119-4